Category: Uncategorized
-
Pharma patent litigation updates: Pfizer faces new COVID UPC suit, Merck and Sun Pharma assert in the UK
Enanta has filed a fresh complaint against Pfizer over its COVID drug Paxlovid in the Unified Patent Court, while Merck has countersued Halozyme over patents related to its injectable drug Keytruda, and Sun Pharma has initiated a new dispute against Incyte in the UK.
-
Federal judge finds Lindis patents unenforceable in leukemia drug dispute, Amgen dodges $50 million payment
The District of Delaware has found two patents asserted in a dispute between Lindis and Amgen over the latterâs leukaemia drug Blincyto âunenforceable due to inequitable conductâ, rendering a prior $50 million jury verdict against Amgen irrelevant.
-
âBeing a decent person is foundation for lasting successâ: outgoing InterDigital IP head
Following her departure from InterDigital last month, Mang Zhu sits down with ip fray to reflect on her time as Head of IP, discuss whatâs next for her, and share what sheâd tell younger women aspiring to get to her position following her decades-long career in SEP licensing.
-
Netflix countersuit against Broadcom thrown out as patent claims deemed abstract, amendment allowed but not necessarily helpful
A strict application of § 101 resulted in the dismissal of one of Netflix’s coutnersuits against Broadcom. An amended complaint would be entertained, though.
-
Chinese court enforces $73 million U.S. judgment: door opens for more foreign order enforceability, including UPC
A Chinese order enforcing a U.S. judgment based on reciprocity could mean the Unified Patent Court will no longer require Chinese companies to pay collateral, with the increased possibility that UPC judgments will now be enforced in China too.
-
UPC gets world’s first serious patent lawsuit against OpenAI: French company alleges infringement by C2PA content authenticity standard
In June, the UPC received not only a record number of cases, but also a number of very high-profile ones.
-
Access Advance reveals previously unknown video streaming patent pool licensors: OPPO, Siemens
The heads of IP at ByteDance, OPPO, MediaTek, Dolby, Tencent and Kuaishou have now issued statements on why they joined the patent program, which now boasts 31 licensors.
-
BREAKING: Philips and Transsion settle Indian SEP dispute over AAC, USAC
The settlement marks the Chinese mobile phone makerâs third publicly known SEP licensing deal this year.
-
UPC Roundup (1 week): language change in light of cross-border dispute; warns against refusal of AASI service; other decisions and new cases
This is a summary of developments in and around the Unified Patent Court (UPC) in the week since our July, 6 2025 UPC Roundup. 1. CoA 1.1 Service-of-process issues in jurisdictions where no UPC judgment has been enforced yet may weigh in favor of security for costs (Chint New Energy Technology & Astronergy v. Jingao Solar)…
-
IP Bridge wins preliminary injunction against BYD in Brazil: no immediate enforcement, but potential fines accumulate
Context: Chinese automaker BYD, which went from tiny numbers to mid-seven-figure annual sales volumes in only a few years, has yet to license cellular standard-essential patents (SEPs). It is being sued in the Unified Patent Court (UPC) and German national courts by Sol IP (May 30, 2025 ip fray article) and IP Bridge (April 2,…